Glaucoma News and Research

Latest Glaucoma News and Research

Older adults with glaucoma at increased risk of falls

Older adults with glaucoma at increased risk of falls

Macular degeneration drug may cause increased IOP

Macular degeneration drug may cause increased IOP

Carl Zeiss Meditec to showcase new clinical and productivity tools at AAO annual meeting

Carl Zeiss Meditec to showcase new clinical and productivity tools at AAO annual meeting

Positive top line results from Shire's LDX phase III study on ADHD

Positive top line results from Shire's LDX phase III study on ADHD

Study: Emerging pharmaceutical platform may produce undesirable effects on eye function

Study: Emerging pharmaceutical platform may produce undesirable effects on eye function

UB scientists discover promising new drug target for Alzheimer's

UB scientists discover promising new drug target for Alzheimer's

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Logistic regression models identify risk factors for open angle glaucoma

Logistic regression models identify risk factors for open angle glaucoma

DMEI dedicates new $46M research and clinical facility

DMEI dedicates new $46M research and clinical facility

Many Canadians are not screening for glaucoma earlier, finds study

Many Canadians are not screening for glaucoma earlier, finds study

Cocaine use linked to increased risk of open-angle glaucoma

Cocaine use linked to increased risk of open-angle glaucoma

Positive results from Clermont's non-preserved latanoprost phase III trial on glaucoma

Positive results from Clermont's non-preserved latanoprost phase III trial on glaucoma

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX licenses rights to Ocunetics' intellectual property

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

CHAM experts available to discuss variety of back-to-school issues

CHAM experts available to discuss variety of back-to-school issues

Amakem receives €18m in Series A round of funding

Amakem receives €18m in Series A round of funding

Contraceptive pill prevents loss of eye sight

Contraceptive pill prevents loss of eye sight

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Patients with diabetes, hypertension more likely to develop open-angle glaucoma

Patients with diabetes, hypertension more likely to develop open-angle glaucoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.